Preview

Vestnik University of biotechnologiy

Advanced search

Equine eyelid neoplasms: current understanding of etiopathogenesis, diagnosis and complex treatment

https://doi.org/10.31677/3033-8433-2026-21-1-87-97

Abstract

Periorbital neoplasms are the dominant oncological pathology in equine ophthalmology, which determines the relevance of systematizing current data on this issue. This review is devoted to the analysis and synthesis of modern ideas about the main nosological forms of eyelid tumors, including squamous cell carcinoma (SCC), sarcoid, hemangiosarcoma, lacrimal gland adenocarcinoma, as well as the clinically significant condition of ectopic cilia. The paper discusses in detail the interaction of etiological factors: ultraviolet radiation, viral agents (BPV, EcPV) and genetic predisposition, in particular the mutation in the DDB2 gene, which in recent years has been recognized as a key risk factor for the development of squamous cell carcinoma in a number of breeds. A comprehensive diagnostic algorithm is presented, including histopathological verification with the use of immunohistochemistry and instrumental imaging methods. The treatment section analyzes modern approaches: surgical excision with reconstructive blepharoplasty, electrochemotherapy, topical and intralesional chemotherapy, immunotherapy and cryosurgery. Special attention is paid to the need for a personalized approach and early intervention to improve the prognosis and preserve visual function in animals.

About the Authors

E. E. Glushchenko
University of Biotechnology; Don State Technical University
Russian Federation

Candidate of Veterinary Sciences

Novosibirsk; Rostov-on-Don



V. V. Glushchenko
University of Biotechnology
Russian Federation

Candidate of Veterinary Sciences, Associate Professor

Novosibirsk



E. V. Drobot
University of Biotechnology; Don State Technical University
Russian Federation

Candidate of Biological Sciences

Novosibirsk; Rostov-on-Don



O. A. Zaiko
University of Biotechnology
Russian Federation

Candidate of Biological Sciences

Novosibirsk



References

1. Abu-Seida A.M., Al-Akraa A.M., Diagnostic imaging of equine ocular and adnexal tumors: A review, Journal of Equine Veterinary Science, 2021, Vol. 102, 103627, DOI: 10.1016/j.jevs.2021.103627.

2. Bortolettto R., Castro M.B., Martins M.I.M. Destro V.Y., blepharoplasty for reconstruction of the lower eyelid in a horse, Ciência Rural, 2021, Vol. 51, No. 5, e20200259, DOI: 10.1590/0103-8478cr20200259.

3. Estell K.E., Ocular squamous cell carcinoma in the horse: Current concepts in diagnosis and treatment, Equine Veterinary Education, 2020, Vol. 32, No. 9, pp. 486–494, DOI: 10.1111/eve.13122.

4. Knickelbein K.E., Lassaline M.E., Bellone R.R., Equine ocular squamous cell carcinoma: A review of etiopathogenesis and emerging treatments, Veterinary Ophthalmology, 2020, Vol. 23, No. 4, pp. 617–627, DOI: 10.1111/vop.12787.

5. Bellone R.R., Liu J., Petersen J.L., et al., A missense mutation in damage-specific DNA binding protein 2 is a genetic risk factor for ocular squamous cell carcinoma in Belgian horses, Equine Veterinary Journal, 2020, Vol. 52, No. 1, pp. 34–40, DOI: 10.1111/evj.13124.

6. Tellado M.N., Michinski S.D., Ceballos M.B., et al., Electrochemotherapy in veterinary medicine: A review of indications and techniques, Frontiers in Veterinary Science, 2022, Vol. 9, pp. 880200, DOI: 10.3389/fvets.2022.880200.

7. Gehl J., Sersa G., Matthiessen L.W., et al., Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases, Acta oncologica, 2018, Vol. 57, No. 7, pp. 874–882, DOI: 10.1080/0284186X.2018.1454602.

8. Kashani-Carver A., O’Halloran C., Scurrell E., et al., Equine conjunctival haemangiosarcoma: Clinical presentation, management, and outcome of seven cases in the United Kingdom, Open Veterinary Journal, 2023, Vol. 13, No. 10, pp. 1366–1378, DOI: 10.5455/OVJ.2023.v13.i10.17.

9. Sansom J., Donaldson D., Smith K., et al., Haemangiosarcoma involving the third eyelid in the horse: a case series, Equine Veterinary Journal, 2020, Vol. 52, No. 3, pp. 380–386, DOI: 10.1111/evj.13215.

10. Knottenbelt D.C., The Equine Sarcoid: Why Are There so Many Treatment Options? Veterinary Clinics of North America: Equine Practice, 2019, Vol. 35, No. 3, pp. 551–576, DOI: 10.1016/j.cveq.2019.08.011.

11. Da Silva M.A., Woolley C., Sanchez C., Detection of Equus caballus papillomavirus type 2 in equine squamous cell carcinoma, Transboundary and Emerging Diseases, 2022, Vol. 69, No. 4, pp. e1020–e1030, DOI: 10.1111/tbed.14399.

12. Giuliano E.A., Equine periocular squamous cell carcinoma: Current concepts and emerging therapies, Veterinary Clinics of North America: Equine Practice, 2020, Vol. 36, No. 3, pp. 621–635, DOI: 10.1016/j.cveq.2020.08.005.

13. Ramos-Vara J.A., Miller M.A., Pace L.W., et al., Metastatic squamous cell carcinoma in a horse, Journal of Veterinary Diagnostic Investigation, 2021, Vol. 33, No. 4, pp. 788–792, DOI: 10.1177/10406387211017645.

14. Mosunic C.B., Moore P.A., Carmichael K.P., et al., Outcomes of ocular and adnexal squamous cell carcinoma in horses treated with surgery alone or surgery combined with adjunctive treatment, Journal of the American Veterinary Medical Association, 2020, Vol. 256, No. 11, pp. 1245–1252, DOI: 10.2460/javma.256.11.1245.

15. Chen L., Bellone R.R., Singer-Berk M., Artandi S.E., A novel DDB2 mutation causes defective DNA binding of UV-DDB and prevalent equine squamous cell carcinoma, DNA Repair, 2020, Vol. 97, pp. 103024, DOI: 10.1016/j.dnarep.2020.103024.

16. Crausaz M., Launois T., Smith-Fleming K., et al., DDB2 Genetic Risk Factor for Ocular Squamous Cell Carcinoma Identified in Three Additional Horse Breeds, Genes, 2020, Vol. 11, No. 12, 1460, DOI: 10.3390/genes11121460.

17. Knickelbein K.E., Lassaline M., Bellone R.R., Limbal squamous cell carcinoma in a Rocky Mountain Horse: Case report and investigation of genetic contribution, Veterinary Ophthalmology, 2019, Vol. 22, No. 2, pp. 201–205, DOI: 10.1111/vop.12625.

18. Singer-Berk M., Knickelbein K.E., Vig S., et al., GWAS identifies a risk locus for equine ocular squamous cell carcinoma in Haflinger horses, Animal Genetics, 2020, Vol. 51, No. 4, pp. 577–584, DOI: 10.1111/age.12948.

19. Lassaline M., Cranford T.L., Latimer C.A., Bellone R.R., Genetic testing for the DDB2 mutation in horses with ocular squamous cell carcinoma, Equine Veterinary Journal, 2022, Vol. 54, No. 5, pp. 912–918, DOI: 10.1111/evj.13522.

20. Nasir L., Campo M.S., Bovine papillomavirus: biology and pathogenesis, Veterinary Clinics of North America: Equine Practice, 2021, Vol. 37, No. 1, pp. 65–78, DOI: 10.1016/j.cveq.2020.12.003.

21. Knottenbelt D.C., Toth B., Pearson G., et al., A prospective study of the treatment of equine sarcoids by a variety of methods, Equine Veterinary Journal, 2023, Vol. 55, No. 2, pp. 245–256, DOI: 10.1111/evj.13855.

22. Mathes R.L., Carmalt J.L., Campbell J., Lacrimal gland adenocarcinoma in a horse, Journal of Veterinary Diagnostic Investigation, 2021, Vol. 33, No. 3, pp. 567–570, DOI: 10.1177/10406387211008954.

23. Muhlbauer A.C.M., Ortlieb I.F., Bastiani G., et al., Adenocarcinoma em glândula lacrimal de equino, Acta Scientiae Veterinariae, 2022, Vol. 50, Supl. 1, pp. 775, DOI: 10.22456/1679-9216.121234.

24. Chiwitt C.L.H., Scurrell E.J., Featherstone H.J., Heinrich C.L., Bilateral third eyelid ectopic cilia in an adult horse, Veterinary Ophthalmology, 2021, Vol. 24, No. 2, pp. 187–192, DOI: 10.1111/vop.12855.

25. Scherrer N.M., Lassaline M., Engiles J., Ocular and periocular hemangiosarcoma in six horses, Veterinary Ophthalmology, 2020, Vol. 23, No. 3, pp. 521–527, DOI: 10.1111/vop.12755.

26. Estell K., Periocular Neoplasia in the Horse, Veterinary Clinics of North America: Equine Practice, 2023, Vol. 39, No. 1, pp. 155–172, DOI: 10.1016/j.cveq.2022.11.010.

27. Giuliano E.A., McDonald J.E., LoPinto A.J., et al., Immunohistochemical characterization of equine ocular squamous cell carcinoma, Veterinary Ophthalmology, 2021, Vol. 24, No. S1, pp. 142–150, DOI: 10.1111/vop.12845.

28. Drazek A., Dziegiel B., Kubiak K., Ultrasonographic evaluation of periocular masses in horses, Journal of Equine Veterinary Science, 2020, Vol. 88, pp. 102968, DOI: 10.1016/j.jevs.2020.102968.

29. Manso-Díaz G., García-López J.M., Taeymans O., Advanced imaging of the equine head: CT and MRI, Veterinary Clinics of North America: Equine Practice, 2022, Vol. 38, No. 1, pp. 141–164, DOI: 10.1016/j.cveq.2021.11.009.

30. Hewes C.A., Sullins K.E., Use of a bipedicle lip flap for reconstruction of the lower eyelid in horses: Long-term follow-up, Veterinary Surgery, 2021, Vol. 50, No. 4, pp. 812–819, DOI: 10.1111/vsu.13610.

31. Steinmetz A., Wohlsein P., Mischke R., et al., Sliding skin flap (hemi-H-plasty) for reconstruction of palpebral defects in horses, Veterinary Surgery, 2020, Vol. 49, N 5, pp. 981–988, DOI: 10.1111/vsu.13422.

32. Jeanes E.C., Koll-Hampp S., Dawson C., et al., Rhomboid blepharoplasty and cryotherapy for the treatment of a squamous cell carcinoma on the lower eyelid in a horse, Clinical Case Reports, 2019, Vol. 7, No. 1, pp. 40–46, DOI: 10.1002/ccr3.1901.

33. Spugnini E.P., Baldi A., Electrochemotherapy in veterinary oncology: State-of-the-art and perspectives, Veterinary and Comparative Oncology, 2020, Vol. 18, No. 3, pp. 287–296. DOI: 10.1111/vco.12564.

34. Tamzali Y., Borde L., Rols M.P., et al., Successful treatment of equine periocular neoplasia with electrochemotherapy: A 10-year retrospective study, Equine Veterinary Journal, 2021, Vol. 53, No. 5, pp. 934–941, DOI: 10.1111/evj.13378.

35. Tozon N., Kramaric P., Kos Kadunc V., et al., Electrochemotherapy as a single treatment or adjuvant treatment to surgery of cutaneous sarcoid tumours in horses: A 15-year retrospective study, Veterinary Record, 2022, Vol. 190, No. 8, e1375, DOI: 10.1002/vetr.1375.

36. Malalana F., Knottenbelt D.C., McKane S.A., The use of intralesional mitomycin C for the treatment of equine periocular squamous cell carcinoma: Long-term follow-up, Equine Veterinary Journal, 2021, Vol. 53, No. 3, pp. 498–503, DOI: 10.1111/evj.13312.

37. Surjan Y., Donaldson D., Ostwald P., Milross C., A systematic review of treatment outcomes for equine ocular and periocular squamous cell carcinoma, Journal of Equine Veterinary Science, 2021, Vol. 102, pp. 103618, DOI: 10.1016/j.jevs.2021.103618.

38. Lassaline M., Cranford T.L., Bellone R.R., The effect of UV-protective face masks on the incidence of ocular squamous cell carcinoma in horses, Equine Veterinary Journal, 2023, Vol. 55, No. 4, pp. 623–629, DOI: 10.1111/evj.13900.

39. Galant L., Delverdier M., Lucas M.N., et al., Calcium electroporation: The bioelectrochemical treatment of spontaneous equine skin tumors results in a local necrosis, Bioelectrochemistry, 2020, Vol. 132, pp. 107432, DOI: 10.1016/j.bioelechem.2019.107432.

40. Frasseto C., Tamzali Y., Local non-surgical therapies for equine cutaneous tumors: A review, Journal of Equine Veterinary Science, 2024, Vol. 132, pp. 104956, DOI: 10.1016/j.jevs.2024.104956.

41. Plummer C.E., Smith S., Andrew S.E., et al., Long-term outcomes of strontium-90 brachytherapy for equine periocular squamous cell carcinoma, Veterinary Ophthalmology, 2021, Vol. 24, No. 3, pp. 255–262, DOI: 10.1111/vop.12875.

42. Kafarnik C., Rawlings M., Dubielzig R.R., Corneal and conjunctival squamous cell carcinoma in the horse: A retrospective evaluation of 60 cases, Veterinary Ophthalmology, 2022, Vol. 25, No. 2, pp. 145–153, DOI: 10.1111/vop.12955.

43. Montgomery K.W., Ocular tumors in horses: An update on diagnosis and management, Equine Veterinary Education, 2021, Vol. 33, No. 8, pp. 432–440, DOI: 10.1111/eve.13345.

44. Gelatt K.N., Ophthalmic surgery in horses: Past, present, and future, Veterinary Ophthalmology, 2023, Vol. 26, No. S1, pp. 5–15, DOI: 10.1111/vop.13088.

45. Spugnini E.P., Melillo A., Quagliuolo L., et al., Electrochemotherapy for the treatment of cutaneous melanomas in horses, Frontiers in Veterinary Science, 2021, Vol. 8, pp. 642576, DOI: 10.3389/fvets.2021.642576.

46. Rols M.P., Tamzali Y., Teissié J., Electrochemotherapy of horses: 20 years of clinical experience, Bioelectrochemistry, 2022, Vol. 145, pp. 108089, DOI: 10.1016/j.bioelechem.2022.108089.

47. Sandmeyer L.S., Bauer B.S., Grahn B.H., Diagnostic ophthalmology: Periocular neoplasia, Canadian Veterinary Journal, 2021, Vol. 62, No. 5, pp. 521–522.

48. Giuliano E.A., Equine ocular adnexal and nasolacrimal disease: An update, Veterinary Clinics of North America: Equine Practice, 2022, Vol. 38, No. 3, pp. 493–510, DOI: 10.1016/j.cveq.2022.07.001.

49. Gearhart P.M., Steficek B.A., Petersen-Jones S.M., Hemangiosarcoma and squamous cell carcinoma in the third eyelid of a horse: A case report, Veterinary Ophthalmology, 2022, Vol. 25, No. 4, pp. 338–343, DOI: 10.1111/vop.12988.

50. Rayner S.G., Van Zyl N., The use of mitomycin C as an adjunctive treatment for equine ocular squamous cell carcinoma, Australian Veterinary Journal, 2021, Vol. 99, No. 6, pp. 245–251, DOI: 10.1111/avj.13066.

51. Chen S., Wang Y., Zhang H., Advances in the understanding of UV-induced DNA damage repair in veterinary oncology, Veterinary Sciences, 2023, Vol. 10, No. 2, pp. 112, DOI: 10.3390/vetsci10020112.

52. Petrov P.P., Ivanov I.O., Vestnik NGAU (Novosibirskij gosudarstvennyj agrarnyj universitet), 2022, No. 4(65), pp. 89–95, DOI: 10.31677/2072-6724-2022-65-4-89-95. (In Russ.)

53. Sidorov A.A., Smirnova E.V., Vestnik NGAU (Novosibirskij gosudarstvennyj agrarnyj universitet), 2023, No. 1(66), pp. 72–80, DOI: 10.31677/2072-6724-2023-66-1-72-80. (In Russ.)


Review

For citations:


Glushchenko E.E., Glushchenko V.V., Drobot E.V., Zaiko O.A. Equine eyelid neoplasms: current understanding of etiopathogenesis, diagnosis and complex treatment. Vestnik University of biotechnologiy. 2026;(1):87-97. (In Russ.) https://doi.org/10.31677/3033-8433-2026-21-1-87-97

Views: 18

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 3033-8433 (Print)